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the target registration, and we used the Dice similarity coefficient to 
classify the registration quality. A secondary aim was to find a FRE-
cutoff value that indicates a good MR-CT-fusion. A third aim was to 
see if there was an additional gain using 4 versus 3 gold fiducials in a 
rigid registration of the MR- and CT-series. 
Materials and Methods: Retrospectively we analysed 18 prostate 
patients treated with curative radiotherapy up to 78 Gy. All patients 
had 3 or 4 gold fiducials implanted in the prostate. All patients had 
performed MR-series within 1 hour after the CT-series, and the two 
series were fused through a rigid registration procedure in the dose 
planning system Oncentra (Elekta). Migration of the fiducials and 
deformation of the prostate can lead to an increased FRE. We 
simulated a systematic displacement of the most cranial fiducial. This 
influenced the fusion of CT- and MR-series, and the FRE and Dice 
similarity coefficients were compared. We simulated a systematic 
displacement in the X- and Y- direction of the fiducial of up to 4 mm. 
We also calculated a value that classified the spread of the fiducials in 
the prostate. The value is calculated from the sum of the distances 
between all the fiducials divided by the sum of the maximum distance 
between all the fiducials if they were located on the prostate wall. 
Results: We found that the spread of the fiducials is very important. A 
small FRE-value from fiducials that are closely spaced can hide a large 
target registration error. We found that a spread of the fiducials with 
a value of 0.6 of the maximum possible spread of fiducials in the 
prostate is a cut-off value that can be used to indicate that a small 
FRE correlates well with a good target registration. We found a clear 
indication that 4 fiducials give a better target registration than 3 
fiducials even when they indicate the same fiducial registration error. 
4 fiducials are more robust when it comes to errors from migration of 
the fiducials and deformation of the prostate. 
Conclusions: It is vital that the 4 fiducials implanted are well-spread 
in the prostate. A small FRE-value does not necessarily indicate a good 
target registration, and the FRE-value should be used in coherence 
with a value that indicates the spread of the fiducials. 4 fiducials are 
superior to 3 fiducials in most cases.  
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Purpose/Objective: Quality assurance for radiotherapy (QART) aims 
to improve patient outcome in Head and Neck (H&N) cancer patient 
included in prospective studies. Three levels of QART were proposed: 
center’s Facility Questionnaire and External Review Dosimetry 
Assessment with Dummy runs (QA level II), prospective Individual Case 
Reviews (ICRs) for 15% of patients (QA level III) and prospective ICRs 
for all patients (QA level IV). The purpose of this study is to assess the 
outcome impact (QAOI) and cost-effectiveness (QACEA) of the three 
levels of QART program, for H&N cancer patient included in the 
EORTC 22071-24071 protocol. 
Materials and Methods: The non-activated phase III of postoperative 
chemo-radiotherapy with EGFR inhibition would have included 600 
patients in 15 European centers. The study primary endpoint was 
local-tumor control on a two years follow-up, expressed as life-years 
without relapse. The follow-up of patients was modeled using a multi-
state model. Parameters of the model were derived from EORTC 
studies, TROG 0202 and RTOG 0525 prospective studies. Simulations 
were performed with a probabilistic sensitivity analysis. Results for 
each QART level were expressed as percentage of mortality and local 
failure on 2 years, and in survival times and life-days without relapse 
on 2 years.  
Results: For the QAOI, the estimated incremental percentage of local 
failure was -2.1% [95%CI: -5.9; -1.8], -4.9% [95%CI: -8.3; -1.5] and -
2.7% [95%CI: -4.6; -1.4], for an increase QART level from II to III, II to 
IV and III to IV, respectively. The estimated incremental survival times 
was 8 days [95%CI: -7; 24], 18 days [95%CI: 4; 34], and 10 days [95%CI: 
4; 18], for an increase QART level from II to III, II to IV and III to IV, 
respectively. The QACEA will be detailed during the congress. 
Conclusions: Patient treated with an increase QART level were 
significantly less likely to recur locally.  
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Purpose/Objective: Hypofractionated stereotactic ablative 
radiotherapy (SABR) for small volume lung tumours precisely delivers 
ablative doses using multiple fixed gantry angle beams or volumetric 
arc therapy (VMAT). The high dose per fraction can result in 
significant delivery times and flattening filter free (FFF) beams 
delivered at much higher dose rates may be advantageous. A study at 
our institution compared dose distributions and delivery accuracy of 
one and two arc VMAT plans created with standard and FFF beams to 
determine appropriate planning class solutions and verification 
methods for lung SABR treatments.  
Materials and Methods: Treatment plans were prepared on suitable 
lung datasets for SABR deliveries of 54Gy in 3 fractions. One and two 
arc VMAT plans were optimised and calculated for standard 6MV 
beams (600MU/min) and 6MV FFF beams (1400MU/min). Analysis of 
the resulting dose distributions included conformity index and organ 
at risk (OAR) doses. Deliveries were verified by in-phantom point dose 
measurements and fluence measurements in 2 dose planes using a 2D 
ion chamber array. 
Results: Plans comprised a single 360° arc or two co-planar 195°arcs 
orientated to avoid the contra-lateral lung. All resulting dose 
distributions satisfied pre-defined dose and dose volume constraints 
when using the same optimisation objectives and priorities regardless 
of energy or beam arrangement. There was a slight improvement in 
conformity index with the FFF energy. The two arc technique resulted 
in lower mean and maximum doses to the contra-lateral lung however 
there was no significant difference in V20Gy and V12.5Gy for the 
combined lung. Total beam on time was approximately 5.6 minutes 
for 6MV and 2.5 minutes for 6MV FFF. Target volume point dose 
measurements in geometrical and semi-anatomical phantoms were 
within 2.5% of calculated for all deliveries. Measured point doses 
outside the target volumes were up to 6.5% different to calculated 
however dose gradients in these low dose regions may have 
contributed to the higher discrepancies. Fluence measurements with a 
2D ion chamber array showed 100% of points within the 3%/3mm dose 
difference / distance to agreement threshold for points above 20% of 
the maximum dose.  
Conclusions: Class solutions for one and two arc VMAT deliveries 
resulting in acceptable dose distributions for SABR lung treatments 
can be achieved with 6MV and 6MV FFF beams. Analysis of the 
resultant dose distributions showed no significant differences between 
plans. There was good agreement between planned and delivered 
point doses within the target volumes and OARs and between planned 
and delivered fluence regardless of beam orientation or energy. FFF 
deliveries are significantly faster than standard which may improve 
the patient experience. The choice of single arc or two arc plans is 
dependant on isocentre position in order to avoid collision as the 
gantry rotates around the patient. 
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Purpose/Objective: To assess the accuracy of plastic scintillation 
detectors (PSDs) for real time in-vivo measurement of the dose to the 
anterior rectal wall for IMRT and to determine the clinical utility of 
daily monitoring of rectal dose for prostate cancer patients. 
Materials and Methods: 58 in-vivo measurements were performed 
during prostate IMRT for the 1st two patients of an IRB approved 
protocol. During each monitored fraction two PSDs were attached to 
the anterior surface of an endorectal balloon to monitor the dose 
delivered to the rectal wall. The balloon was inserted into the patient 
